Organization
Celgene Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Celgene Corp.
... paclitaxel), REVLIMID® (lenalidomide), and VIDAZA® (azacitidine) in China under a license from Celgene Corporation.1 Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of ...
... a broad array of both solid tumor and hematologic cancers. BeiGene and Celgene Corporation have a global strategic collaboration for the development of tislelizumab in ...
... Celgene is walking away from navicixizumab, a bispecific antibody that became OncoMed's lead ...
... a broad array of both solid tumor and hematologic cancers. BeiGene and Celgene Corporation have a global strategic collaboration for the development of tislelizumab in ...
... 19.10. Immunocore 19.9. Cellular Biomedicine Group 19.8. Cellectis 19.7. Cell Medica 19.6. Celgene 19.5. CARsgen Therapeutics 19.4. bluebird bio 19.3. Autolus 19.2. Adaptimmune Therapeutics 19.1. ...
... financing was led by existing investor OrbiMed, with participation from new investors Celgene Corporation and Alexandria Venture Investments. Silverback's proprietary ImmunoTAC technology and integrated R&D ...
... helps the company's partners in the Fortune 500, including BB&T, EMD Millipore, Celgene and Merck, better serve and engage their customers through new, contextualized workflows. ...
... millions of dollars a year as CEO of New Jersey pharmaceutical company Celgene. As of July, Hugin had pumped $15.5 million of his own money ...
... a broad array of both solid tumor and hematologic cancers. BeiGene and Celgene Corporation have a global strategic collaboration for the development of tislelizumab in ...
... Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that Evotec and Celgene Corporation ('Celgene') have entered into a third long-term strategic drug discovery and development ...
Subscribe now for full coverage on Celgene Corp.
Start My Free Trial